Dihydro Montelukast is a pharmaceutical intermediate primarily used in the synthesis and development of drugs targeting respiratory conditions, such as asthma and allergic rhinitis. As a derivative of Montelukast, it functions as a leukotriene receptor antagonist, aiding in the reduction of airway inflammation and constriction. It is valuable in research for managing chronic respiratory symptoms and preventing asthma exacerbations. Additionally, it is investigated for applications in other inflammatory conditions through immune response modulation. Often incorporated into combination therapies, it supports enhanced efficacy in respiratory disease management.